Stay updated on INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site version has been updated from v3.4.1 to v3.4.2; no user-facing changes to the study details page were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:53:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The change is a backend revision update (v3.4.1 added, v3.4.0 removed) with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T13:26:06.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with a revision note of v3.4.0, while removing the previous capitalization variant and the No FEAR Act data label.
    Difference
    0.1%
    Check dated 2026-01-29T06:54:16.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The update timestamp label changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T04:39:23.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T02:45:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A consolidated Locations section listing all participating states has been added, and the previous per-state location entries were removed. The page shows Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-24T21:38:38.000Z thumbnail image

Stay in the know with updates to INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.